Media Center


20

2019

-

06

This variety is currently in the preclinical research stage.


In collaboration with 301 Hospital, CART-19 was approved by the ethics committee at 301 Hospital in May 2017 and was applied clinically in June 2017. As of February 2018, a total of 15 cases of acute lymphoblastic leukemia were treated. All 15 patients had minimal residual disease before reinfusion...